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ABSTRACT
Preoperative differential diagnosis of gastric submuco-
sal tumors has generally been difficult because they are 
covered with normal mucosa. However, recent advances 
in endoscopic ultrasound (EUS)-guided sampling of 
submucosal gastrointestinal lesions have made it pos-
sible to achieve preoperative differential diagnosis of 
gastric submucosal tumors. A 76-year-old woman was 
referred to our hospital with a gastric submucosal tumor. 
The tumor was observed in the antrum of the stomach. 
It was preoperatively diagnosed as a schwannoma after 
immunohistochemical evaluation of a biopsy speci-
men, obtained using endoscopic ultrasound-guided fine 
needle aspiration. A computed tomography scan of the 
abdomen revealed lymphadenopathies near the tumor 
indicating the possibility of lymph node metastasis from 
the gastric tumor. The patient underwent laparoscopic 
distal gastrectomy with D1 + lymph node dissection. 
The resected tumor was a submucosal tumor measuring 
65 × 45 × 35 mm; it was histopathologically diagnosed 
as a schwannoma. Resected lymph nodes were enlarged 
in the absence of lymph node metastasis as a result of 
reactive lymphadenopathy. A definitive preoperative 
diagnosis of gastric schwannoma is possible using im-
munohistochemical staining techniques and EUS-guid-
ed sampling techniques. After definitive preoperative 
diagnosis of gastric schwannoma, minimal surgery is 
recommended to achieve R0 resection.
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Mesenchymal tumors of the gastrointestinal (GI) tract 
mainly comprise a spectrum of spindle cell tumors that 
include gastrointestinal stromal tumors (GISTs), leiomy-
omas, leiomyosarcomas, and schwannomas.1 Immuno-
histochemical examination of the specimens obtained 
from a tumor is essential to make a definitive diagnosis. 
Preoperative differential diagnosis of gastric submucosal 
tumors has generally been difficult because they are cov-
ered with normal mucosa; this makes it difficult to ob-
tain specimens. However, recent advances in endoscopic 
ultrasound (EUS)-guided sampling of submucosal GI 
lesions have made it possible to achieve preoperative 
differential diagnosis of gastric submucosal tumors;2 this 
enables physicians to easily decide on the optimal treat-
ment strategy. In this report, we present a 76-year-old 
woman with preoperative diagnosis of gastric schwan-
noma with enlargement of the regional lymph nodes of 
the stomach.
PATIENT REPORT
An asymptomatic 76-year-old woman was referred to 
our hospital because of the presence of a gastric submu-
cosal tumor. The patient underwent appendectomy as 
a child and cholecystectomy in her 40s. There was no 
significant past medical, family, or psychosocial histo-
ry. The upper GI series showed a smooth-marginated 
protruded lesion at the greater curvature of the antrum 
of stomach (Fig. 1); upper GI endoscopy revealed that 
this lesion measured 38 mm (Fig. 2a). Endoscopic ul-
trasonography (EUS) showed a well-defined hypoecho-
ic mass arising from the proper muscle layer of the 
stomach; an endoscopic ultrasound-guided fine needle 
aspiration biopsy was performed (Fig. 2b). Histological 
evaluation revealed a spindle cell tumor with a fascicular 
pattern. Immunohistochemical analysis indicated that 
the tumor was positive for S-100 and negative for c-kit, 
CD34, α-SMA, and desmin. The preoperative histolog-
ical diagnosis was gastric schwannoma. A computed 
tomography (CT) scan of the abdomen demonstrated a 
protruded lesion measuring 45 × 37 mm at the antrum 
of the stomach and lymphadenopathies near the tumor 
(Fig. 3a). The 18-fluorodeoxyglucose (FDG) positron 
emission tomography (PET) and CT scans indicated 
high uptake of 18-FDG in the tumor at the antrum of 
the stomach [standardized uptake value (SUV) max, 
5.89–6.81] and slight uptake in the enlarged lymph node 
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Fig. 1. Upper gastrointestinal X-ray showing the smooth-margin-
ated protruded lesion at the greater curvature of the antrum of the 
stomach (arrow).
Fig. 2. Endoscope image. a: Upper gastrointestinal endoscopy showing the smooth protruded lesion measuring 38 mm at the greater 
curvature of the antrum of the stomach. b: Endoscopic ultrasonography image showing a well-defi ned hypoechoic mass arising from the 
proper muscle layer of the stomach (arrow).
(SUVmax, 2.07–2.02)(Fig. 3b). Because of the possibili-
ty of lymph node metastasis, we performed laparoscopic 
distal gastrectomy with D1 + lymph node dissection. 
 Macroscopically, the gastric mass covered by mu-
cosa measured 65 × 45 × 35 mm, with the cut surface 
having the appearance of a firm lobulated yellowish 
white tumor. The tumor was located mainly in the prop-
er muscle layer (Fig. 4). Microscopic examination of 
the resected and H and E-stained specimens revealed 
a spindle cell neoplasm arranged in a palisade manner 
with abundant collagen fi bers. There was lymphoid cuff-
ing (Fig. 5a). Immunohistochemical staining revealed 
that the tumor cells were positive for S-100 and negative 
for c-kit and neurofi laments (Figs. 5b–d). There were no 
tumor cells in the resected enlarged lymph nodes, indi-
cating reactive lymphadenopathies. These histopatholog-
ical and immunohistochemical findings are consistent 
with the presence of a gastric schwannoma with reactive 
lymphadenopathies. 
DISCUSSION
Schwannomas, in other words neurinomas or neurilem-
momas, are benign neurogenic tumors originating from 
Schwann cells, which normally wrap around the axons 
of the peripheral nerves. Theoretically, schwannomas 
can develop anywhere along the peripheral course of 
a nerve. However, they most commonly occur in the 
head and neck, but rarely in the GI tract. In the GI tract, 
the stomach is the most common gastrointestinal site 
of schwannoma, which constitute 0.2% of gastric neo-
plasms.3, 4 The typical presentation of gastric schwanno-
ma is as a submucosal tumor with spindle cell histology. 
GIST, which are the most common mesenchymal tumor 
of the stomach, have the same presentation as gastric 
schwannoma. Despite strong morphological similarities, 
these tumors are heterogeneous regarding their im-
munophenotypes. In 1988, Daimaru et al. successfully 
identifi ed schwannoma as a primary GI tumor based on 
positive S-100 staining.5 GIST also became a distinct GI 
tumor diagnostic category when it was discovered that 
nearly all GIST cells express c-kit protein.1, 6 Before the 
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Fig. 3. CT image. a: CT image showing a protruded lesion measuring 45 × 37 mm at the antrum of the stomach (white arrow), and en-
largement of the regional lymph nodes of the stomach (black arrow). b: 18-FDG positron emission tomography CT image showing high 
uptake of 18-FDG in the tumor at the antrum of the stomach (SUVmax, 5.89–6.81) (white arrow) and slight uptake in the lymph nodes 
(SUVmax, 2.07–2.02) (black arrow). CT, computed tomography; FDG, fl uorodeoxyglucose; SUV, standardized uptake value.
Fig. 4. The tumor was located mainly in the proper muscle layer. a: Gastric mass covered by mucosa measuring 65 × 45 × 35 mm, b: with 
the cut surface showing a fi rm lobulated yellowish white tumor. 
recognition of S-100 antigen and c-kit antigen in gastric 
schwannomas and in GISTs, these neoplasms were most 
often classified as leiomyomas, leiomyosarcomas, or 
gastrointestinal autonomic nerve tumors.1, 4–6 With the 
advent of immunohistochemical staining techniques and 
ultrastructural evaluation, it is now possible to identify 
these neoplasms based on their distinct immunophe-
notypes. Furthermore, recent advances in EUS-guided 
sampling of gastrointestinal submucosal lesions make 
it possible to make a preoperative differential diagnosis 
of gastric submucosal tumors. In fact, in our case pre-
operative diagnosis of gastric schwannoma was made 
by means of an immunohistochemical examination of 
specimens obtained from the tumor by EUS-guided 
sampling. 
 Surgical resection is the only possible treatment 
for gastric schwannoma.3, 7 The size and location of the 
tumor, as well as its relationship with the surrounding 
organs, are important factors in determining the type of 
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subtotal or even total gastrectomy, are all acceptable 
operations for the complete removal of the tumor.8 Lapa-
roscopic techniques can also be used.9 Lymph node dis-
section is not required because it has been reported that 
gastric schwannoma is a benign tumor and is unlikely 
to metastasize to the lymph nodes. In our case, however, 
there were enlarged lymph nodes with moderate uptake 
of 18-FDG; this indicated the possibility of lymph node 
metastasis and the presence of another tumor such as 
malignant lymphoma that had developed in the lymph 
nodes. Shayanfar et al. reported a schwannoma that 
originated in the regional lymph nodes of the stom-
ach.10 Furthermore, Murase et al. reported a malignant 
schwannoma of the esophagus with lymph node me-
tastasis.11 Considering the possibility of the presence of 
tumor cells in the enlarged lymph node, we performed 
laparoscopic distal gastrectomy with D1+ lymph node 
dissection in the present case. Postoperative histopatho-
logical examination of the enlarged lymph nodes after 
resection revealed that there were no tumor cells present, 
indicating the presence of reactive lymphadenopathies. 
The correlation between gastric schwannoma and en-
larged lymph nodes remains unclear. Because enlarged 
lymph nodes are regional lymph nodes and are located 
near the tumor, it is likely that gastric schwannoma can 
induce reactive lymphadenopathies. In this regard, the 
18-FDG positron emission tomography and CT scans 
showed high uptake in gastric schwannoma in our case. 
Komatsu et al. reported the fi rst case of gastric schwan-
noma that exhibited increased accumulation of 18-FDG 
on PET imaging.12 It has not been clarifi ed why benign 
schwannomas show increased 18-FDG uptake on PET; 
Kawabe et al. reported that 18-FDG accumulated in 
infl ammatory tissue involving lymphocyte proliferation 
in chronic tonsillitis.13 It has been reported that cuff-like 
lymphoid aggregates are recognized around the tumor 
in 97% of gastric schwannomas;14 this also occurred in 
the present case. Therefore, it is likely that lymphocyte 
proliferation in gastric schwannoma is related to enlarge-
ment of the regional lymph node observed in our case. 
Thus far, the majority of previous series in the literature 
have demonstrated no lymph node metastasis regarding 
gastric schwannoma.15, 16 Therefore, local resection of the 
stomach and extirpation of enlarged lymph nodes might 
be suffi cient in the present case.
 Gastric schwannoma is considered a benign tumor. 
It is unclear whether pathological parameters such as 
tumor size and mitotic rate have prognostic signifi cance 
in this tumor, as in the cases of GISTs reported thus far; 
this is because gastric schwannoma is rare compared 
with GIST and experience concerning their long-term 
follow-up is limited. In this regard, Voltaggio et al. re-
ported that some gastric schwannomas exceed 10 cm in 
size, and a minority have a mitotic rate > 5/50 high-pow-
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Fig. 5. Photomicrographs. a: There was lymphoid cuffi ng. Bar = 200 µm. b: Tumor cells were positive for S-100 and c: negative for c-kit. d: 
Immunostained neurofi laments. Bar = 50 μm.
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er fi elds (HPFs); none of these 51 gastric schwannoma 
cases showed evidence of aggressive behavior.17 Despite 
this, these authors advised caution regarding gastric 
schwannomas with higher mitotic rates (> 10/50 HPFs), 
because experience from their long-term follow-up was 
limited.17 In fact, one case of malignant gastric schwan-
noma has been recently reported;18 in this case, immu-
nohistochemistry revealed that the tumor cells were pos-
itive for S-100 protein and negative for c-kit and smooth 
muscle actin. Mitosis was scattered with 10 mitoses per 
50 HPFs, indicating the aggressiveness of this tumor. 
This patient died at 5 months after surgery as a result of 
multiple liver metastases. Therefore, careful follow-up 
is required in gastric schwannoma patients with higher 
mitotic rates (> 10/50 HPFs) after surgery.
 A definitive preoperative diagnosis of gastric 
schwannoma is possible using immunohistochemical 
staining techniques and EUS-guided sampling tech-
niques. After defi nitive preoperative diagnosis of gastric 
schwannoma, minimal surgery is recommended to 
achieve R0 resection.
The authors declare no conﬂ ict of interest.
REFERENCES
  1 Nishida T, Hirota S. Biological and clinical review of stro-
mal tumors in the gastrointestinal tract. Histol Histopathol. 
2000;15:1293-301. PMID: 11005253.
  2 Mekky MA, Yamao K, Sawaki A, Mizuno N, Hara K, Nafeh 
MA, et al. Diagnostic utility of EUS-guided FNA in pa-
tients with gastric submucosal tumors. Gastrointest Endosc. 
2010;71:913-9. PMID: 20226456.
  3 Melvin WS, Wilkinson MG. Gastric schwannoma. Clinical 
and pathologic considerations. Am Surg. 1993;59:293-6. 
PMID: 8489097.
  4 Sarlomo-Rikala M, Miettinen M. Gastric schwannoma-a 
clinicopathological analysis of six cases. Histopathology. 
1995;27:355-60. PMID: 8847066.
  5 Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwan-
noma of the gastrointestinal tract: a clinicopathologic and 
immunohistochemical study. Hum Pathol. 1988;19:257-64. 
PMID: 3126126.
  6 Miettinen M, Majidi M, Lasota J. Pathology and diagnostic 
criteria of gastrointestinal stromal tumors (GISTs): a review. 
Eur J Cancer. 2002;38 Suppl 5:S39-51. PMID: 12528772.
  7 Prevot S, Bienvenu L, Vaillant JC, de Saint-Maur PP. Benign 
schwannoma of the digestive tract: a clinicopathologic and 
immunohistochemical study of fi ve cases, including a case of 
esophageal tumor. Am J Surg Pathol. 1999;23:431-6. PMID: 
10199472.
  8 Bandoh T, Isoyama T, Toyoshima H. Submucosal tumors 
of the stomach: a study of 100 operative cases. Surgery. 
1993;113:498-506. PMID: 8488466.
  9 Basso N, Rosato P, De Leo A, Picconi T, Trentino P, Fantini A, 
et al. Laparoscopic treatment of gastric stromal tumors. Surg 
Endosc. 2000;14:524-6. PMID: 10890957.
10 Shayanfar N, Shahzadi S. Schwannoma In A Perigastric 
Lymph Node: A Rare Case Report. Iran J Pathol. 2008;3:43-6.
11 Murase K, Hino A, Ozeki Y, Karagiri Y, Onitsuka A, Sugie 
S. Malignant schwannoma of the esophagus with lymph node 
metastasis: literature review of schwannoma of the esophagus. 
J Gastroenterol. 2001;36:772-7. PMID: 11757750.
12 Komatsu D, Koide N, Hiraga R, Furuya N, Akamatsu T, 
Uehara T, et al. Gastric schwannoma exhibiting increased 
fluorodeoxyglucose uptake. Gastric Cancer. 2009;12:225-8. 
PMID: 20047128.
13 Kawabe J, Okamura T, Shakudo M, Koyama K, Wanibuchi H, 
Sakamoto H, et al. Two cases of chronic tonsillitis studied by 
FDG-PET. Ann Nucl Med. 1999;13:277-9. PMID: 10510887.
14 Hou YY, Tan YS, Xu JF, Wang XN, Lu SH, Ji Y, et al. 
Schwannoma of the gastrointestinal tract: a clinicopatholog-
ical, immunohistochemical and ultrastructural study of 33 
cases. Histopathology. 2006;48:536-45. PMID: 16623779.
15 Fujiwara S, Nakajima K, Nishida T, Takahashi T, Kurokawa Y, 
Yamasaki M, et al. Gastric schwannomas revisited: has pre-
cise preoperative diagnosis become feasible? Gastric cancer. 
2013;16:318-23. PMID: 22907486.
16 Zheng L, Wu X, Kreis ME, Yu Z, Feng L, Chen C, et al. Clin-
icopathological and immunohistochemical characterisation 
of gastric schwannomas in 29 cases. Gastroenterol Res Pract. 
2014;2014:202960. PMID: 24688535.
17 Voltaggio L, Murray R, Lasota J, Miettinen M. Gastric 
schwannoma: a clinicopathologic study of 51 cases and critical 
review of the literature. Hum Pathol. 2012;43:650-9. PMID: 
22137423.
18 Takemura M, Yoshida K, Takii M, Sakurai K, Kanazawa A. 
Gastric malignant schwannoma presenting with upper gastro-
intestinal bleeding: a case report. J Med Case Rep. 2012;6:37. 
PMID: 22277785.
